Mosqitter Transforms Mosquito Traps Into Disease-Tracking AI Network

Dengue cases have surged dramatically, jumping from 6.5 million reported instances globally in 2023 to 14.6 million in 2024, according to the World Health Organization. The spread reflects how climate change, shifting precipitation patterns, and international movement are creating new habitats where disease-carrying mosquitoes can flourish.

Mosqitter, a 30-person company based in Pennsylvania, believes the solution extends beyond simply eliminating mosquitoes. The startup engineered chemical-free traps that replicate human signals—warmth, odor, and breathing patterns—to attract and capture female mosquitoes, the only sex that bites. Anastasiia Romanova, the company's co-founder and chief executive, explained to TechCrunch that Mosqitter aimed to introduce more environmentally responsible alternatives to the chemical-dependent approaches that dominate the market today.

The company's growth has been substantial. Mosqitter now operates more than 5,000 devices across five continents, a dramatic increase from approximately 250 units when TechCrunch last profiled the startup in 2022. The company's trajectory began in Ukraine in 2019 with research and development, followed by commercial launch in 2021.

Mosqitter's strategy centers on the reproductive cycle of female mosquitoes. These insects seek blood meals before laying eggs roughly every three weeks, typically depositing 100 to 200 eggs at a time. Romanova stated, "We saw an opportunity: if we could catch the female mosquito at the point when she is about to lay eggs, we could potentially reduce the mosquito population and prevent it from growing. That's why we combined elements such as heat, similar to the temperature of human skin; scent that imitates human skin odor; and light. In the Grand model, which is the company's highest-end offering, we also use CO2 to imitate human breathing."

The company is now leveraging artificial intelligence to classify the mosquitoes its devices capture. A computer-vision system examines biological traits to differentiate between species, with the process involving three validation steps. Romanova described the approach: "You can think about it as three judges analyzing a case and producing a verdict." The system processes images through a neural network, cross-references external datasets, and incorporates entomologist verification before assigning a confidence score reflecting alignment across assessments.

Environmental inputs—weather conditions, wind patterns, and moisture levels—feed into Mosqitter's analytical framework. As the company accumulates more data, it intends to employ these variables to project shifts in mosquito populations and forecast potential disease threats.

https://www.youtube.com/embed/oLAH4RfCZXQ?si=Z7LUr39_aXW4uwTd&autoplay=1&mute=1

Product Lineup and Market Strategy

Mosqitter currently offers two hardware products. The Mosqitter Grand serves larger areas and public spaces, while the Mosqitter Mini addresses residential settings and functions as a portable monitoring unit. The company will formally unveil its Febris Monitoring System next month, introducing a data-focused platform for tracking mosquito populations and assessing disease transmission potential.

Romanova emphasized an important distinction: "It's very important to understand that Febris does not diagnose disease. We can't say with certainty that a particular mosquito carries dengue. What we can say is that a particular mosquito species is present, and knowing that can help indicate an increased potential risk associated with diseases that species can transmit."

Olga Diachuk, chief operating officer and co-founder, indicated that Mosqitter is pursuing B2B partnerships globally, particularly seeking distributors with established networks and government relationships. While the hardware targets broad markets, Febris is designed for institutional buyers—government agencies, public health departments, mosquito-control authorities, airports, municipalities, and universities requiring ongoing surveillance.

Brazil, burdened by high dengue prevalence, represents a significant expansion opportunity. Mosqitter has established local manufacturing and sales infrastructure there. The startup also identifies the United States, Greece, India, Ukraine, and Nigeria as critical markets, each with tailored sales approaches. In Greece, the company partners with an established pest-control firm. Within the U.S., Mosqitter sells the Mini device directly to consumers via Amazon and its website. The company is collaborating with the UK Health Security Agency to deploy Febris at Heathrow and Gatwick airports, recognizing that international travel can introduce mosquitoes and diseases from distant regions.

Romanova noted, "We think this part of the business could grow substantially with the Febris Monitoring System because governments are major buyers of mosquito-surveillance data."

Pricing and Financial Projections

The Mosqitter Mini retails at $199, while the professional-grade Grand system is priced at $1,999. Revenue generation stems from hardware sales, with Febris introducing a recurring income stream through monitoring services, dashboards, analytics, and data offerings.

Mosqitter projects revenue exceeding $1 million in 2026, according to Romanova. Though Febris revenue has only recently begun flowing, the company forecasts the data business could generate more than $3.5 million in the following year, based on contract values currently under negotiation.

The startup is pursuing a $5 million funding round structured in two phases: an initial $1 million tranche followed by a $4 million installment. The company has tied this structure to milestones associated with its Febris Monitoring System development. To date, Mosqitter has secured $1.9 million in total funding.

The company's name carries an interesting backstory. Despite common assumptions, "Mosqitter" does not combine "mosquito" and "quitter," according to Diachuk. Rather, it merges "mosquito" and "eater," terminology that held greater relevance when the company's primary focus centered on mosquito capture.